Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 40INDUSTRY 22NETWORK 7NIH 3OTHER_GOV 2UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Breast 3Plasma cell 1

Conditions

Breast Neoplasms 3Osteoporosis 2Neoplasm Metastasis 1

Interventions

Cyclophosphamide 80Paclitaxel 53Trastuzumab 41Tamoxifen 40Doxorubicin 39Specimen Handling 35Docetaxel 35Magnetic Resonance Spectroscopy 34Radiotherapy 33Taxes 30Fluorouracil 26Chemotherapy, Adjuvant 26Carboplatin 24Epirubicin 22Biopsy 22Filgrastim 21Neoadjuvant Therapy 19Methotrexate 19aldesleukin 17Peripheral Blood Stem Cell Transplantation 16Bevacizumab 14Anastrozole 14exemestane 13Lapatinib 13veliparib 12CMF regimen 12sargramostim 11Goserelin 11Fulvestrant 11Capecitabine 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Zoledronic Acid × Breast × Clear all
NCT00049452 2014-01-06

Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer

National Cancer Institute (NCI)

Phase 3 Completed
120 enrolled
Breast

Breast Neoplasms, Osteoporosis

NCT00072020 2013-08-02

Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00114270 2013-03-26

Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density

National Cancer Institute (NCI)

Phase NA Completed
Breast

Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡